Clinical Trial

Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer

Name: Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer — clinical trial record (NCT06387368)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This is a prospective, multicenter, randomized, open, parallel controlled clinical study to evaluate the efficacy and safety of Huaier Granules combined with capecitabine in the treatment of unresectable pancreatic cancer.

Trial Details

NCT Number	NCT06387368
Lead Sponsor	Xi'an Jiaotong University Collaborators: LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology
Conditions	Pancreatic Cancer Non-resectable
Enrollment	488 participants
Start Date	2024-05
Primary Completion	2028-03 (estimated)
Study Completion	2028-08 (estimated)
Updated on ClinicalTrials.gov	2024-04-29